SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$17.53
+0.57 (+3.36%)
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+127.0% upside
Low Target
$34.71
Average Target
$39.80
High Target
$61.57
Current Price
$17.53
Current
$17.53
$17.53
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Scenario Analysis
Bear Case
$34.71
98.0%
Low target
Base Case
$39.80
+127.0%
Avg target
Bull Case
$61.57
+251.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$25.32
-30.8% from high
52-Week Low
$10.42
+68.2% from low
Target vs 52W High
$39.80
+57.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |